Baxter said it is evaluating other potential locations, including contract manufacturers, to support its supply needs if necessary.
News & Features
NuVasive said the next evolution of its Reline system allows for greater procedural flexibility while enhancing visibility and access.
The company asked the court to dismiss a negligence case involving St. Jude Medical's Riata ST lead, but a federal judge denied the motion, allowing the case to proceed.
Endologix promoted from within to fill the CEO seat. Will this strategy help the struggling EVAR company up its game?
Angiodynamics CEO Jim Clemmer assures investors that the company is ready and able to execute M&A opportunities, either in terms of divestitures or acquisitions.
A new study offers more evidence that single-use bronchoscopes could be a better alternative to reusable devices.
MD+DI News Editor Amanda Pedersen talks about recent M&A trends in medtech and the attributes that make companies stand out as potential acquisition targets.
Researchers in the UK have achieved the first 3D printing of human corneas that can potentially be used in replacement surgeries. In doing so, they have paved the way for an unlimited and easy-to-fabricate supply of new corneas to patients that need them, they said. Key to the achievement by...
The San Francisco, CA-based company has raised $26.6 million in a series C round to help further commercialize its Accuryn Monitoring System.
Verily and ResMed will form a joint venture to develop software solutions to identify and treat sleep apnea, as well as study the financial aspects of the disease if it goes undiagnosed and untreated.
At least one analyst sees a bright future for Nevro, even if the company is holding the short end of the stick at the conclusion of a longstanding patent dispute with Boston Scientific.
Visura Technologies has received FDA clearance for a disposable camera that can help physicians view the upper airway during transesophageal echocardiogram (TEE) procedures.
Medtronic and UnitedHealthcare shared how a unique value-based partnership demonstrated a 27% decline in the rate of preventable hospital admissions for Medtronic insulin pump users compared to patients on multiple daily insulin injections.